Currently Viewing:
American Society of Clinical Oncology Annual Meeting
Currently Reading
Persephone Trial: Cutting Trastuzumab Duration by Half Safer, Efficacious in HER2-Positive Breast Cancer
May 29, 2018
Despite USPSTF Recommendations, Lung Screening Rates Low Among Heavy Smokers
May 31, 2018
Nelarabine With Chemotherapy Boosted Outcomes in Pediatric and YA Patients With T-Cell Cancers
June 01, 2018
Dr Leonard B. Saltz on Deciding When a Patient Should Receive NGS Testing
June 02, 2018
Promising Early Phase Results With bb2121 CAR T Treatment in Relapsed Refractory Multiple Myeloma
June 02, 2018
Dr Peter Paul Yu Discusses the Impact of Health Information Technology in Oncology
June 02, 2018
Identifying Rational Immunotherapy Combinations for Glioblastoma: A Progress Report
June 02, 2018
Dr James Lin Chen Outlines Information Needs in Era of Precision Medicine
June 02, 2018
Ellen Miller Sonet Highlights Financial Burdens of Patients With Cancer
June 02, 2018
Utilization Management in Oncology: Current Strategies and a Path Forward
June 02, 2018
Immune Checkpoint Inhibitors Improve Outcomes in Mismatch Repair Deficient CRC, but Can Induce irAEs
June 02, 2018
ZUMA-1: Response to Axi-cel at Three Months Prognostic for Remission in B-cell Lymphoma
June 03, 2018
Cetuximab With Chemoradiation Worse Than Chemoradiation Alone in Older Patients With HNSCC
June 03, 2018
Dr Michael Thompson: The Role of Precision Medicine in the Community Setting
June 03, 2018
Dr Victoria Villaflor Outlines Challenges With Pursuing Precision Medicine
June 03, 2018
Clinical Trials: Sharing the Road With Real-World Evidence
June 04, 2018
Phase 3 TAILORx Results Confirm Chemotherapy Unnecessary in 70% of Women With Early-Stage Breast Cancer
June 04, 2018
KEYNOTE-042 Confirms First-Line Pembrolizumab Superior to Chemotherapy in PD-L1–Low Advanced NSCLC
June 04, 2018
Cemiplimab, in GOG 3016, Looks to Break New Ground for Immunotherapy in Cervical Cancer
June 04, 2018
Nearly Half of Patients With Metastatic CSCC Respond to Cemiplimab, on Fast Track at FDA
June 04, 2018
Opdivo Plus Chemo Boosts Progression-Free Survival 26% Over Chemo Alone in Late-Stage NSCLC
June 04, 2018
Managing Cancer-Related Pain in the Era of the Opioid Crisis
June 06, 2018
Discussing the Cost Burden of Cancer With Patients
June 06, 2018
Study Underscores Value of PROs in Improving Lung Cancer Survival
June 07, 2018

Ellen Miller Sonet: The Importance of Cancer Care Providers Informing Patients of Treatment Costs

Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.


Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.

Transcript

Why is it so important to communicate the financial burden of cancer treatment with patients?

The research that we’ve done suggests that patients don’t know what they’re in for, financially, when they’re making treatment decisions. Consider, for example, buying a car. Would you ever buy a car without knowing the price? Would you buy a refrigerator without knowing the price? Patients are signing on to treatment plans without understanding the financial consequences, and that’s just not right. Both ASCO and the academies of medicine have said that talking about cost is fundamental to shared decision making, high-quality cancer care, and a partnership around doing what’s best for the patient. These kinds of issues have to be explored before treatment decisions are made.

What are best practices for successfully communicating and assisting the patient with these burdens?

The team approach to cancer care is key to making sure that patients really understand the implications of treatment decisions. So, once a physician sees a patient, and they talk about a treatment plan, it’s then really important to sit down and understand how the patient can afford this treatment. We have seen practices where there is a team of navigators, nurses, or financial aid folks that come in and talk to the patients and take them through their co-pays, deductibles, and formulary issues, and help them understand what the impact of treatment will be on their finances.

If that isn’t done, then patients are blind-sided and often suffer the consequences for years. It takes a village. Cancer care is very complex. Patients are overwhelmed with the emotional, physical, spiritual, family, and financial aspects of being sick, and there are many resources that can help support patients on many levels. Patients need to know about them. Providers need to help them understand that these resources exist, and they can make the experience of having cancer less difficult for patients if they know about and avail themselves of these resources.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up